Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM230D is a member of the FAM230 gene family, defined by sequence similarity in particular chromosomal regions (notably chromosome 22 LCRs/LCR22s). It is annotated as a long intergenic non-coding RNA (lincRNA) gene, meaning it is transcribed but does not encode a protein product^5. These lincRNA genes are part of a repeated genomic structure involving clincRNA sequences, spacers, and pseudogenes, which are implicated in gene family expansion and chromosomal segmental duplications. The specific biological function of FAM230D remains uncharacterized; related FAM230 lincRNAs exhibit tissue-specific expression (e.g., testes and fetal heart) and may be involved in development, but direct evidence for regulatory roles or disease association is lacking^5. FAM230D should not be confused with similarly named protein-coding genes (e.g., FAM83D) that are implicated as cancer biomarkers or therapeutic targets[1][3]. No drugs, mechanisms of action, or clinical safety data have been reported for FAM230D due to its non-coding RNA nature^5.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 230 member D (FAM230D).